IJCS | Volume 32, Nº5, September/October 2019

547 Valle et al. Drug efficacy in acute Chagas myocarditis Int J Cardiovasc Sci. 2019;32(5):546-550 Case Report and dilated heart cardiac chambers. Laboratory tests revealed leukocytosis with lymphocytosis, hyponatremia and moderate increase of liver enzymes. The initial electrocardiogram is shown in Figure 1. Conventional treatment was started for severe heart failure with intravenous and oral administration of furosemide, carvedilol at increasingdoses, spironolactone, and angiotensinconverting enzyme (ACE) inhibitors. After 10 days of treatment,although seropositivity for CD was still not confirmed by laboratory tests, it was decided to empirically administer oral BZ at conventional dose (2-4 mg/kg q. 12 h), based on recent family history, clinical symptoms, and lack of complete resolution using conventional treatment. In a few days, the patient showed quick improvement and complete resolution of edema and dyspnea. A second ECG was obtained (Figure 2) months later, showing complete normalized tracing. A concomitant transthoracic echocardiogram revealed normal cardiac chambers and normal left ventricular ejection fraction (63%). This significant response to BZ indicates that this drug can be effective in the treatment of the acute phase of Chagas myocarditis, but not the chronic phase. 4,5 Discussion Possible modes of transmission of CD include: feces of the infected vector deposited on the skin and/ or mucous membranes, while the vector sucks blood; transplacental vertical transmission which depends on maternal immune status, parasite strain and placental factors; lab accidents caused by violation of biosafety regulations; organ transplantation from an infected donor (this may occur by migration of contaminated individuals to non-endemic areas, inwhich serological test for Chagas is not made), oral transmission by ingestion of contaminated food, including açaí and sugarcane juice. In our case, the most probable mode was the oral transmission. The insects could be attracted by the light of the inside of the açaí grinding machine, or the fruit pulp could get contaminated because of lack of hygiene during fruit collection, transportation or processing. 6 In case of handcrafted food in areaswith triatomines, good cooking and pasteurization regulations are essential. The pasteurization has been adopted for the açaí paste exported from the Amazon and other regions of Brazil. The symptoms presented by the patient and the course of disease coincide with other studies and are in accordance with the Ministry of Brazil guidelines, which state that people living in endemic areas, who have prolonged fever (> seven days), facial edema, hepatosplenomegaly, and manifestations of acute heart failure, should be treated empirically with BZ or NFX, even in the absence of a positive serology, aiming to reduce the mortality rate. 7-9 To start empirical treatment of clinical and epidemiological manifestations compatible with CD with antiparasitics, even when the first serological test is negative, is supported and described in the guidelines for surveillance, prevention, control and clinical management of acute CD transmitted by food. In this case report, early treatment with BZ resulted in complete electrocardiographic normalization, along with complete resolution of symptoms. The electrical changes of acute Chagas myocarditis can be completely reversed by antiparasitic drugs. Bastos et al., 10 described the clinical outcome of 13 patients with acute CD acquired through oral transmission from two urban outbreaks in northeastern Brazil. They reported that ventricular repolarization abnormalities persisted in 50% of the patients with the antiparasitic treatment, while sinus bradycardia was observed in 18%. Left ventricular ejection fraction normalized in two out of three patients with initially depressed ventricular function, while pericardial effusion disappeared. 10 Conclusion Complete reversal of ECG changes associated with acute Chagas myocarditis is achieved by antiparasitic therapy. This may positively impact long-termprognosis. Author contributions Conception and design of the research: Valle JETMR, Pérez-Riera AR. Acquisition of data: Valle JETMR. Analysis and interpretation of the data: Pérez-Riera AR. Writing of the manuscript: Valle JETMR, Barros RB, Pérez-Riera AR. Critical revision of the manuscript for intellectual content: Valle JETMR, Abreu LC, Barros RB, Raimundo RD. Potential Conflict of Interest No potential conflict of interest relevant to this article was reported.